Overview

Ramelteon for Insomnia Comorbid With Asthma

Status:
Terminated
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
This trial will test the efficacy and safety of ramelteon, a selective melatonin agonist, on patients with insomnia comorbid with asthma.
Phase:
Phase 3
Details
Lead Sponsor:
Northwestern University
Collaborator:
Takeda